{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:56:22Z","timestamp":1789710982080,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12936-015-0970-2","type":"journal-article","created":{"date-parts":[[2015,11,14]],"date-time":"2015-11-14T05:44:51Z","timestamp":1447479891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["High efficacy of two artemisinin-based combinations: artesunate\u00a0+\u00a0sulfadoxine-pyrimethamine and artemether-lumefantrine for falciparum malaria in Yemen"],"prefix":"10.1186","volume":"14","author":[{"given":"Ahmed A.","family":"Adeel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niaz Abdo","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Aljasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar M.","family":"Almohager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H.","family":"Galab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"AlMahdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansor H.","family":"Mahammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"AlDarsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahiya A.","family":"Salaeah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Atta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghasem","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Warsame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Barrette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan El","family":"Mohammady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania A.","family":"Nada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,14]]},"reference":[{"key":"970_CR1","volume-title":"World malaria report, 2014","author":"WHO","year":"2014","unstructured":"WHO. World malaria report, 2014. Geneva: World Health Organization; 2014."},{"key":"970_CR2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/B978-0-12-407706-5.00003-4","volume":"82","author":"RW Snow","year":"2013","unstructured":"Snow RW, Amratia P, Zamani G, Mundia CW, Noor AM, Memish ZA, et al. The malaria transition on the Arabian Peninsula: progress toward a malaria-free region between 1960\u20132010. Adv Parasitol. 2013;82:205\u201351.","journal-title":"Adv Parasitol"},{"key":"970_CR3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/1756-3305-7-351","volume":"7","author":"A Bamaga","year":"2014","unstructured":"Bamaga A, Mahdy MA, Mahmud R, Lim YA. Malaria in Hadhramout, a southeast province of Yemen: prevalence, risk factors, knowledge, attitude and practices (KAPs). Parasit Vectors. 2014;7:351.","journal-title":"Parasit Vectors"},{"key":"970_CR4","unstructured":"WHO. Report on the inter-country workshop on monitoring therapeutic efficacy of antimalarial drugs, Annex 5: main results of monitoring drug resistance of falciparum malaria by country. Sana\u2019a, Republic of Yemen, 21\u201325 April 2002, WHO-EM\/MAL\/281\/E\/L. http:\/\/whqlibdoc.who.int\/emro\/2002\/WHO-EM_MAL_281_E_L.pdf . Accessed 11 June 2015."},{"key":"970_CR5","unstructured":"WHO. Monitoring antimalarial drug resistance. Report of WHO Consultation, Geneva, Switzerland, 3\u20135 December 2001. WHO monographs WHO\/CDS\/CSR\/EPH\/2002.7."},{"key":"970_CR6","unstructured":"Abdul-Kader R. Studies on drug resistant Plasmodium falciparum malaria in Yemen, PhD Thesis, University of Liverpool, 2006. http:\/\/library.liv.ac.uk\/search~S8?\/lTHESIS+20651.MUB\/lthesis+20651+mub\/-3%2C-%2C0%2CE\/frameset&FF=lthesis+20651+mub&1%2C1%2C . Accessed 24 Feb 2011."},{"key":"970_CR7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1475-2875-10-245","volume":"10","author":"RA Mubjer","year":"2011","unstructured":"Mubjer RA, Adeel AA, Chance ML, Hassan AA. Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implications. Malar J. 2011;10:245.","journal-title":"Malar J."},{"key":"970_CR8","unstructured":"WHO. Susceptibility of Plasmodium falciparum to antimalarial drugs: report on global monitoring: 1996\u20132004. WHO\/HTM\/MAL\/2005."},{"key":"970_CR9","unstructured":"Bloland P. Drug resistance in malaria. World Health Organization, Geneva, WHO\/CDS\/CSR\/DRS\/2001.4."},{"key":"970_CR10","first-page":"829","volume":"33","author":"MT Al-Maktari","year":"2003","unstructured":"Al-Maktari MT, Bassiouny HK. Malaria status in Al-Hodeidah Governorate, Republic lof Yemen. Part II: human factors causing the persistence of chloroquine resistant P. falciparum local strain. J Egypt Soc Parasitol. 2003;33:829\u201339.","journal-title":"J Egypt Soc Parasitol"},{"key":"970_CR11","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3855\/jidc.2528","volume":"7","author":"AS Bin Ghouth","year":"2013","unstructured":"Bin Ghouth AS. Availability and prescription practice of anti-malaria drugs in the private health sector in Yemen. J Infect Dev Ctries. 2013;7:404\u201312.","journal-title":"J Infect Dev Ctries"},{"key":"970_CR12","unstructured":"WHO. Guidelines for the Treatment of Malaria, 3rd edn. World Health Organization: Geneva. 2015. http:\/\/www.who.int\/malaria\/publications\/atoz\/9789241549127\/en\/ ."},{"key":"970_CR13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(03)15162-8","volume":"363","author":"M Adjuik","year":"2004","unstructured":"Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N, et al. Artesunate combinations for treatment of malaria: meta-analysis. Lancet. 2004;363:9\u201317.","journal-title":"Lancet"},{"key":"970_CR14","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0140-6736(99)10237-X","volume":"355","author":"L Seidlein von","year":"2000","unstructured":"von Seidlein L, Milligan P, Pinder M, Bojang K, Anyalebechi C, Gosling R, et al. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet. 2000;355:352\u20137.","journal-title":"Lancet"},{"key":"970_CR15","first-page":"CD003125","volume":"18","author":"A Omari","year":"2007","unstructured":"Omari A, Gamble C, Garner P. Artemether-lumefantrine for treating uncomplicated falciparum malaria. Cochrane Database Syst Rev. 2007;18:CD003125.","journal-title":"Cochrane Database Syst Rev."},{"key":"970_CR16","unstructured":"WHO. Methods for Surveillance of antimalarial drug efficacy. World Health Organization: Geneva. 2009. http:\/\/www.who.int\/malaria\/publications\/atoz\/9789241597531\/en\/ . Accessed 23 Oct 2015."},{"key":"970_CR17","unstructured":"WHO. Methods and techniques for clinical trials on anti-malarial drug efficacy: genotyping to identify parasite populations. World Health Organization: Geneva. 2008. http:\/\/www.who.int\/malaria\/publications\/atoz\/9789241596305\/en\/ . Accessed 23 Oct 2015."},{"key":"970_CR18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455\u201367.","journal-title":"N Engl J Med"},{"key":"970_CR19","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1056\/NEJMc0805011","volume":"359","author":"H Noedl","year":"2008","unstructured":"Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359:2619\u201320.","journal-title":"N Engl J Med"},{"key":"970_CR20","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.clpt.2006.08.016","volume":"80","author":"KI Barnes","year":"2006","unstructured":"Barnes KI, Little F, Smith PJ, Evans A, Watkins WM, White NJ. Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications. Clin Pharmacol Ther. 2006;80:582\u201396.","journal-title":"Clin Pharmacol Ther"},{"key":"970_CR21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1124\/pr.57.1.4","volume":"57","author":"A Gregson","year":"2005","unstructured":"Gregson A, Plowe C. Mechanisms of resistance of malaria parasites to antifolates. Pharmacol Rev. 2005;57:117\u201345.","journal-title":"Pharmacol Rev"},{"key":"970_CR22","first-page":"970","volume":"91","author":"B Bredenkamp","year":"2001","unstructured":"Bredenkamp B, Sharp B, Mthembu SD, Durrheim DN, Barnes KI. Failure of sulfadoxine\u2013pyrimethamine in treating Plasmodium falciparum malaria in KwaZulu-Natal. S Afr Med J. 2001;91:970\u20131.","journal-title":"S Afr Med J"},{"key":"970_CR23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0035-9203(93)90431-O","volume":"87","author":"WM Watkins","year":"1993","unstructured":"Watkins WM, Mosobo M. Treatment of Plasmodium falciparum malaria with pyrimethamine\u2013sulfadoxine: selective pressure for resistance is a function of long elimination half- life. Trans R Soc Trop Med Hyg. 1993;87:75\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"970_CR24","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1098\/rstb.1999.0426","volume":"354","author":"N White","year":"1999","unstructured":"White N. Antimalarial drug resistance and combination chemotherapy. Philos Trans R Soc Lond Biol Sci. 1999;354:739\u201349.","journal-title":"Philos Trans R Soc Lond Biol Sci."},{"key":"970_CR25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1475-2875-4-28","volume":"4","author":"A Abdo-Rabbo","year":"2005","unstructured":"Abdo-Rabbo A, Bassili A, Atta H. The quality of antimalarials available in Yemen. Malar J. 2005;4:28.","journal-title":"Malar J."},{"key":"970_CR26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.actatropica.2013.07.010","volume":"128","author":"R Abdul-Ghani","year":"2013","unstructured":"Abdul-Ghani R, Farag HF, Allam AF, Shawky SM, Al-Mekhlafi AM. Mutant Plasmodium falciparum chloroquine resistance transporter in Hodeidah, Yemen : association with parasitologic indices and treatment-seeking behaviors. Acta Trop. 2013;128:473\u20138.","journal-title":"Acta Trop"},{"key":"970_CR27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000163049","volume":"18","author":"AM Al-Kabsi","year":"2009","unstructured":"Al-Kabsi AM, Al-Shamahy HA, Al-Harazy AH, Harmal NS. The therapeutic efficacy of sulfadoxine\/pyrimethamine against Plasmodium falciparum in Yemen. Med Princ Pract. 2009;18:62\u20136.","journal-title":"Med Princ Pract"},{"key":"970_CR28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/1475-2875-12-244","volume":"12","author":"S Al-Hamidhi","year":"2013","unstructured":"Al-Hamidhi S, Mahdy MA, Al-Hashami Z, Al-Farsi H, Al-Mekhlafi AM, Idris MA, et al. Genetic diversity of Plasmodium falciparum and distribution of drug resistance haplotypes in Yemen. Malar J. 2013;12:244.","journal-title":"Malar J."},{"key":"970_CR29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.actatropica.2013.12.022","volume":"132","author":"R Abdul-Ghani","year":"2014","unstructured":"Abdul-Ghani R, Farag HF, Allam AF, Shawky SM. Prevailing Plasmodium falciparum dihydrofolate reductase 108-asparagine in Hodeidah, Yemen: a questionable sulfadoxine-pyrimethamine partner within the artemisinin-based combination therapy. Acta Trop. 2014;132:39\u201344.","journal-title":"Acta Trop"},{"key":"970_CR30","doi-asserted-by":"crossref","first-page":"12025","DOI":"10.1073\/pnas.0905922106","volume":"106","author":"ER Lozovsky","year":"2009","unstructured":"Lozovsky ER, Chookajorn T, Brown KM, Imwong M, Shaw PJ, Kamchonwongpaisan S, et al. Stepwise acquisition of pyrimethamine resistance in the malaria parasite. Proc Natl Acad Sci USA. 2009;106:12025\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"key":"970_CR31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1475-2875-12-255","volume":"12","author":"NB Gadalla","year":"2013","unstructured":"Gadalla NB, Abdallah TM, Atwal S, Sutherland CJ, Adam I. Selection of pfdhfr\/pfdhps alleles and declining artesunate\/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum 8\u00a0years after deployment in eastern Sudan. Malar J. 2013;12:255.","journal-title":"Malar J"},{"key":"970_CR32","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/1475-2875-10-214","volume":"10","author":"P Mula","year":"2011","unstructured":"Mula P, Fern\u00e1ndez-Mart\u00ednez A, de Lucio A, Ramos JM, Reyes F, Gonz\u00e1lez V, et al. Detection of high levels of mutations involved in anti-malarial drug resistance in Plasmodium falciparum and Plasmodium vivax at a rural hospital in southern Ethiopia. Malar J. 2011;10:214.","journal-title":"Malar J."},{"key":"970_CR33","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/tmi.12458","volume":"20","author":"M Warsame","year":"2015","unstructured":"Warsame M, Hassan AM, Barrette A, Jibril AM, Elmi HH, Arale AM, et al. Treatment of uncomplicated malaria with artesunate plus sulfadoxine-pyrimethamine is failing in Somalia: evidence from therapeutic efficacy studies and Pfdhfr and Pfdhps mutant alleles. Trop Med Int Health. 2015;20:510\u20137.","journal-title":"Trop Med Int Health."},{"key":"970_CR34","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4269\/ajtmh.2011.11-0069","volume":"85","author":"M Makanga","year":"2011","unstructured":"Makanga M, Bassat Q, Falade CO, Premji ZG, Krudsood S, Hunt P, et al. Efficacy and safety of artemether-lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: a pooled analysis. Am J Trop Med Hyg. 2011;85:793\u2013804.","journal-title":"Am J Trop Med Hyg"},{"key":"970_CR35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/1475-2875-13-291","volume":"13","author":"MA Makanga","year":"2014","unstructured":"Makanga MA. Review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission. Malar J. 2014;13:291.","journal-title":"Malar J."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-015-0970-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T23:39:20Z","timestamp":1498261160000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.malariajournal.com\/content\/14\/1\/449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,14]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["970"],"URL":"https:\/\/doi.org\/10.1186\/s12936-015-0970-2","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,14]]},"article-number":"449"}}